Companies: 10,795·Total market cap: $144.5T
Biofrontera AG

Biofrontera AG

BFFTFOTCHealthcare
$0.33
$-6.60(-95.24%)
Market Cap$19346895
P/E Ratio—
52W High$22.68
52W Low$0.33
Overview
Foreign Private Issuer · Files 20-F / 6-K

Biofrontera AG (BFFTF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001712641 · BFFTF · OTC · as of Jun 10, 2026

Filing snapshot

497
Total Filings
4
Latest Form
2025-09-18
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001712641 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2021-04-12
Fiscal Year End
Apr 12, 2021
Accession No.
0001493152-21-008577
Primary Document
form20-f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001712641 · Accession 0001493152-21-008577

Latest Key Filings

6-KQuarterly Report
Quarterly Report
2022-03-10
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2025-07-09
View
EFFECTEFFECT
EFFECT
2022-03-11
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-03-10
View
15F-12B15F-12B
15F-12B
2022-03-09
View
POS AMPOS AM
POS AM
2022-03-09
View
S-8 POSS-8 POS
S-8 POS
2022-03-09
View
SC 13D/ASC 13D/A
AMENDMENT NO. 16 TO SCHEDULE 13D
2022-02-25
View
2525
25
2022-02-24
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-02-24
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-02-22
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-02-14
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2022-02-10
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-02-01
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2022-01-13
View
6-KCurrent Report (Foreign Issuer)
Current Report (Foreign Issuer)
2021-12-29
View
Showing 1–15 of 496 filingsForm 4 / 144 hidden· 497 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001712641  |  Exchange: OTC · Healthcare

Biofrontera AG (OTC: BFFTF) has submitted 497 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001712641, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Biofrontera AG's most comprehensive regulatory disclosure. The most recent Biofrontera AG 10-K was filed on 2021-04-12 for fiscal year ending 2021. Historical BFFTF 10-K annual reports are available from 2017 through 2021.

Investors researching Biofrontera AG SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
PCHM SEC Filings →VNNYF SEC Filings →GRAMF SEC Filings →ATHJF SEC Filings →TGPHF SEC Filings →SRNEQ SEC Filings →NXTTF SEC Filings →HMPSF SEC Filings →
→ BFFTF Financials→ BFFTF Earnings→ BFFTF Insider Trades

Frequently Asked Questions

BFFTF SEC Filings · 8 questions

Biofrontera AG (BFFTF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 497 filings and access original documents at no cost. Biofrontera AG's CIK is 0001712641.

BFFTF SEC filingsBiofrontera AG SEC documentsfind BFFTF 10-K